Ipsos Healthcare Rolls Out Normative Database

In the UK, Ipsos Healthcare has launched the 'EquityVision Normative Database', which contains seven years' worth of Rx pharma brand health and brand equity research.

Comprising data covering 15,800 records from 1,800 brands, across 36 markets, and 130 therapy areas, the database provides a perspective on brand health in Rx markets in different geographies and indications, as well as benchmarks across brand performance KPIs.

Ipsos says the database, which can be tailored for specific situations, has been developed to enable clients to interpret and contextualise brand performance, set up brand KPIs and expectations, and identify priorities.

Michael Spedding (pictured), Global CEO of Ipsos Healthcare, says the product was developed 'to address a fundamental need of healthcare clients - to put things in perspective', and will add 'significant value' to any brand health study the firm runs for its clients.

Web site: www.ipsos.com .